Stockreport

Catabasis Pharma's edasalonexent shows positive effect in mid-stage DMD study; shares up 62% [Seeking Alpha]

Catabasis Pharmaceuticals, Inc.  (CATB) 
Last catabasis pharmaceuticals, inc. earnings: 3/10 08:05 am Check Earnings Report
US:NASDAQ Investor Relations: ir.catabasis.com/investor-overview
PDF Catabasis Pharma's edasalonexent shows positive effect in mid-stage DMD study; shares up 62%Thinly traded nano cap Catabasis Pharmaceuticals (CATB+61.6%) is up on a whop [Read more]